Skip to main content


Log in

Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript



Definitive evaluation of surgical specimens obtained after neoadjuvant chemoradiation therapy (CRT) is important for assessing additional treatment or prognosis in patients with esophageal squamous cell carcinoma (ESCC). In this study, we examined the histological prognostic factors for ESCC patients treated with CRT and determined an appropriate strategy for their evaluation.

Patients and methods

The present study involved 38 consecutive ESCC patients who underwent CRT followed by curative operation. CRT consisted of 5-fluorouracil plus cisplatin and 40 Gy of radiation. We examined histological variables as follows: CRT effect on primary tumor (T-effect: T-effective/T-ineffective), tumor depth (pT), lymph node metastases (pN: pN0/N1), number of lymph node metastases (number-pN), lymphatic invasion, and venous invasion. Univariate and multivariate analyses were performed to examine the independent prognostic factors. Survivals and mode of recurrence were then evaluated according to the independent prognostic factors.


In the univariate analyses, T-effect, pN, number-pN, lymphatic invasion, and venous invasion were found to be prognostic factors with p < 0.01, and pT was a factor with p < 0.05. In the multivariate analysis, pN and T-effect were independent prognostic factors. The five-year survival rate of pN0 patients was more than 75%, even though the T-effect was poor. The 5-year survival rate of patients judged as pN1/T-effective was 50%, whereas all of the pN1/T-ineffective patients died within 2 years with relapse disease.


The evaluation method using both pN status and T-effect is useful for assessing prognosis of ESCC patients treated with neoadjuvant CRT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others


  1. Natsugoe S, Okumura H, Matsumoto M et al (2006) Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus 19:468–472

    Article  PubMed  CAS  Google Scholar 

  2. John MJ, Flam MS, Mowry PA et al (1989) Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. Cancer 632:397–403

    Google Scholar 

  3. Naunheim KS, Petruska P, Roy TS et al (1992) Preoperative chemotherapy and radiotherapy for esophageal carcinoma. J Thorac Cardiovasc Surg 103:887–893

    PubMed  CAS  Google Scholar 

  4. Swisher SG, Hofstetter W, Wu TT et al (2005) Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241:810–817

    Article  PubMed  Google Scholar 

  5. Law S, Kwong DL, Wong KH et al (2006) The effects of neoadjuvant chemoradiation on pTNM staging and its prognostic significance in esophageal cancer. J Gastrointest Surg 10:1301–1311

    Article  PubMed  Google Scholar 

  6. Sobin LH, Wittwkind CH (2002) TNM classification of malignant tumors, International Union Against Cancer, 6th edn. Wiley, New York

    Google Scholar 

  7. Japanese Society for Esophageal Diseases (1999) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, 9th edn. Kanehara, Tokyo

    Google Scholar 

  8. Natsugoe S, Yoshinaka H, Shimada M et al (2001) Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma. Ann Surg 234:613–618

    Article  PubMed  CAS  Google Scholar 

  9. Okumura H, Natsugoe S, Matsumoto M et al (2005) The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma. Br J Cancer 92:284–289

    PubMed  CAS  Google Scholar 

  10. Kita Y, Natsugoe S, Okumura H et al (2006) Expression of osteopontin in oesophageal squamous cell carcinoma. Br J Cancer 95:634–638

    Article  PubMed  CAS  Google Scholar 

  11. Owaki T, Matsumoto M, Okumura H et al (2012) Endoscopic ultrasonography is useful for monitoring the tumor response of neoadjuvant chemoradiation therapy in esophageal squamous cell carcinoma. Am J Surg 203:191–197

    Article  PubMed  Google Scholar 

  12. Schneider PM, Baldus SE, Metzger R et al (2005) Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg 242:684–692

    Article  PubMed  Google Scholar 

  13. Mariette C, Piessen G, Briez N et al (2008) The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg 247:365–371

    Article  PubMed  Google Scholar 

  14. Meguid RA, Hooker CM, Taylor JT et al (2009) Recurrence after neoadjuvant chemoradiation and surgery for esophageal cancer: does the pattern of recurrence differ for patients with complete response and those with partial or no response? J Thorac Cardiovasc Surg 138:1309–1317

    Article  PubMed  Google Scholar 

  15. Okumura H, Natsugoe S, Matsumoto M et al (2005) Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma. J Surg Oncol 91:84–89

    Article  PubMed  CAS  Google Scholar 

  16. Takatori H, Natsugoe S, Okumura H et al (2005) Predictive value of COX-2 for the effect of chemoradiotherapy on esophageal squamous cell carcinoma. Oncol Rep 13:697–701

    PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Hiroshi Okumura.

About this article

Cite this article

Okumura, H., Uchikado, Y., Matsumoto, M. et al. Prognostic factors in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiation therapy. Int J Clin Oncol 18, 329–334 (2013).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: